Clinical Trial
Accepted on 20 Oct 2025
Population pharmacokinetics/pharmacodynamics and safety of YPEG-rhGH in elderly subjects
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1651323
Type at least 3 characters
840 articles
Original Research
Published on 17 Oct 2025
QSAR-based physiologically based pharmacokinetic (PBPK) modeling for 34 fentanyl analogs: model validation, human pharmacokinetic prediction and abuse risk insights
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1692293
- 825 views
Clinical Trial
Published on 16 Oct 2025
Comparative study of the pharmacokinetics, efficacy and safety of ET-26 in elderly and non-elderly subjects: the results of a phase I clinical trial
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1665322
- 232 views
Methods
Accepted on 14 Oct 2025
Ex vivo perfusion model of mouse liver and its application to analyze the effects of OCT1 deficiency
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1629421
Review
Published on 13 Oct 2025
The impact of the exposome on cytochrome P450-mediated drug metabolism
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1639646
- 974 views
Clinical Trial
Published on 08 Oct 2025
A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636504
- 1,564 views
Review
Accepted on 07 Oct 2025
Strategy Advancements in Placental Pharmacokinetics: From In Vitro Experiments to In Silico Prediction
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694886
- 141 views
Editorial
Published on 06 Oct 2025
Editorial: Diverse functions of drug transporters
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1697775
- 619 views
Original Research
Published on 30 Sep 2025
Characterization of trazodone metabolic pathways and species-specific profiles
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636919
- 1,365 views
Original Research
Published on 30 Sep 2025
Study on cerebrospinal fluid meropenem, vancomycin and tigecycline monitoring in patients with central nervous system infection following neurosurgery under different drug regimens
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1666168
- 1,758 views
Original Research
Accepted on 29 Sep 2025
1H-NMR-based metabolomics study of Rifafour in a healthy Kramnik (C3HeB/FeJ) tuberculosis mouse model
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1661938
- 383 views
Clinical Trial
Published on 26 Sep 2025
Pharmacokinetics, safety and tolerability of ipatasertib in combination with palbociclib and fulvestrant in patients with advanced breast cancer in a phase Ib study
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1670582
- 1,501 views
Original Research
Published on 26 Sep 2025
Pharmacokinetic-pharmacodynamic target attainment analyses as support for meropenem dosing regimens in critically ill adult and elderly patients with Pseudomonas aeruginosa infections
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1643553
- 1,918 views
Original Research
Published on 23 Sep 2025
Evaluation the inhibitory effect of nicardipine on the metabolism of quetiapine
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1567044
- 2,836 views
Original Research
Published on 19 Sep 2025
Stability study of common vasoactive drugs diluted in five types of solutions
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1670183
- 1,749 views
Original Research
Published on 17 Sep 2025
Risk factor identification for delayed excretion in pediatric high-dose methotrexate therapy: a machine learning analysis of real-world data
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662718
- 1,585 views